SCHEMBL4929677

SCHEMBL4929677

N#Cc1cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)cc(NC2CCC2)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 3/20 0.38
EGLN1 Q9GZT9 4/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CXCR3 P49682 2/20 0.33
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33
TAOK1 Q7L7X3 1/20 0.33
TAOK3 Q9H2K8 1/20 0.33
USP5 P45974 2/20 0.33
FLT1 P17948 1/20 0.32
EGLN3 Q9H6Z9 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
AKR1B1 P15121 1/20 0.32
PLAU P00749 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717898 0.96 MRGPRX4 (0.35) MRGPRX4EGLN1PDE4APDE4BPDE4C
SCHEMBL4934191 0.91 EGLN1 (0.36) MRGPRX4EGLN1PDE4APDE4BPDE4C
SCHEMBL5718269 0.90 THRA (0.40) MRGPRX4EGLN1
SCHEMBL5717902 0.88 MRGPRX4 (0.33) MRGPRX4HSD17B10CXCR3TAOK1TAOK3
SCHEMBL4926882 0.88 PDE4A (0.36) MRGPRX4PDE4APDE4BPDE4CPDE4D
SCHEMBL4931877 0.86 PDE4A (0.35) MRGPRX4PDE4APDE4BPDE4CPDE4D
SCHEMBL4931806 0.86 F2 (0.39) PDE4APDE4BPDE4CPDE4DHSD17B10
SCHEMBL4929549 0.85 MRGPRX4 (0.40) MRGPRX4EGLN1HSD17B10ITGB3ITGA2B
SCHEMBL4930880 0.84 MRGPRX4 (0.41) MRGPRX4EGLN1HSD17B10ITGB3ITGA2B
SCHEMBL4932680 0.84 MRGPRX4 (0.42) MRGPRX4TAOK1TAOK3PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA MRGPRX4 119/4885EGLN1 2616/4885PDE4A 897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.